The STZ-treated rat is an excellent model for studying the role of GH in diabetes, since STZ treatment results in the suppression of pulsatile GH release and low plasma GH levels[11]: this low GH model can then be compared to STZ + GH replacement to identify GH-related changes in diabetes. The gene discussed is GH1; the disease is diabetes mellitus.